The 20 Best Adult Soft Tissue Sarcoma Doctors Near Me in Ann Arbor, MI

Scott Schuetze is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Schuetze is rated as an Elite provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Liposarcoma, Adult Soft Tissue Sarcoma, Angiosarcoma, and Myxoid Liposarcoma.

Patrick Grohar is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Grohar is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Ewing Sarcoma, Osteosarcoma, Adult Soft Tissue Sarcoma, and Rhabdoid Tumor. Dr. Grohar is board certified in Pediatric Hematology-Oncology.

Dr. Angeles is an Associate Professor with Tenure of Surgery, Associate Professor of Dermatology, and Faculty Member in the Cancer Biology PhD Program at the University of Michigan in the Division of Surgical Oncology. She earned her medical degree at Tufts University School of Medicine. She completed general surgery residency at New York Presbyterian-Weill Cornell Medical Center. While in residency she completed a two-year basic/translational science Surgical Oncology Research Fellowship at Memorial Sloan-Kettering Cancer Center (MSKCC) focusing on the molecular biology and novel therapeutics for sarcoma. After residency, Dr. Angeles returned to MSKCC and completed a clinical Complex Surgical Oncology Fellowship. Dr. Angeles is board-certified in both General Surgery and Complex General Surgical Oncology. She is the Director of the Regional Cancer Therapies Clinic at University of Michigan/Rogel Cancer Center. Dr. Angeles is a nationally recognized surgeon-scientist dedicated to advancing cancer care through innovative research and compassionate patient care. As the lead investigator for multiple clinical trials at the Rogel Cancer Center, she is at the forefront of developing new treatments for melanoma and sarcoma. Her laboratory studies the immune system’s role in fighting cancer, with a special focus on how resident memory T cells can help create long-lasting protection against tumors. By combining basic science and translational research, Dr. Angeles and her team are working to transform discoveries in the lab into effective new therapies for patients. Dr. Angeles’s research has been supported by the American Cancer Society, the Melanoma Research Alliance, the Society of Surgical Oncology, and the National Institutes of Health’s National Cancer Institute (NCI-NIH).Committed to excellence in both science and patient care, Dr. Angeles is a Fellow of the American College of Surgeons, a Fellow of the Society of Surgical Oncology, and an active member of professional societies including the American Society of Clinical Oncology (ASCO), the Society of Surgical Oncology (SSO), the Connective Tissue Oncology Society (CTOS), and the Society for Immunotherapy of Cancer (SITC). She also serves as Chair of the Society of Surgical Oncology's Research Committee, helping to shape the future of cancer research and treatment.Clinical Specialization:Dr. Angeles is a board-certified surgical oncologist whose clinical practice focuses on patients with soft tissue cancers including sarcoma, melanoma, and non-melanoma cutaneous malignancies. Dr. Angeles cares for patients in a robust multidisciplinary fashion and provides education and counseling to her patients in order to allow shared decision making for the surgical management of their disease. Dr. Angeles is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Liposarcoma, Adult Soft Tissue Sarcoma, Melanoma, Splenectomy, and Nephrectomy. Dr. Angeles is board certified in Surgery and Complex General Surgical Oncology.

Rashmi Chugh is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Chugh is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Ganglioneuroblastoma, Rhabdomyosarcoma, Rhabdoid Tumor Predisposition Syndrome, and Rhabdoid Tumor.

Dr. Biermann serves as Director of the Musculoskeletal Oncology Program at the University of Michigan. Her clinical interests include malignant and benign tumors of soft tissue and bone, both primary and metastatic. Her practice includes both adults and children. Dr. Biermann chairs the Multidisciplinary Sarcoma Tumor Board, a collaborative cancer center group including medical and pediatric oncologists, pathologist, diagnostic radiologists, and radiation therapists. The Sarcoma clinic meets weekly. The University of Michigan Sarcoma team engages in patient care, clinical trials, and basic science research. In addition to her regional responsibilities, Dr. Biermann has been active in national committee and administrative work. She chairs the National Comprehensive Cancer Network (NCCN) Bone Tumors Panel. She is past president of the Musculoskeletal Tumor Society (MSTS). She is a member of the American Society of Clinical Oncology (ASCO). She sits on the Orthopaedic Research and Education Foundation (OREF) Grant Board. Her active research program has included more than 87 publications in the areas of musculoskeletal tumors and in the impact of the Internet on patient education. Dr. Biermann is the University of Michigan Medical Director for the Sarcoma Program and the Orthopaedic Surgery Residency Program Director. Dr. Biermann is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Ewing Sarcoma, Bone Tumor, Chondrosarcoma, Osteosarcoma, and Hip Replacement. Dr. Biermann is board certified in Orthopedic Surgery.

Dr. Geoffrey Siegel is a Michigan native who received his Medical Doctorate Degree at the Detroit Medical Center and his residency in Orthopaedic Surgery at Wayne State University. After finishing his fellowship in Orthopaedic Oncology at Vanderbilt University Medical Center in Nashville, Tennessee, he joined the Department of Orthopaedic Surgery at the University of Michigan as Clinical Assistant Professor.Dr. Siegel's clinical interests are in the treatment of benign and malignant disease, both metastatic as well as primary bone cancer in adults and children. His surgical interests include limb salvage and complex musculoskeletal reconstruction. He enjoys both resident and community physician education in the field of Musculoskeletal Oncology. Dr. Siegel is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Bone Tumor, Chondrosarcoma, Epithelioid Sarcoma, and Hip Replacement. Dr. Siegel is board certified in Orthopedic Sports Medicine and Orthopedic Surgery.

Dr. Lesly Dossett, MD, MPH, is the Maud T. Lane Research Professor for Cancer Quality Improvement and Chief of the Division of Surgical Oncology at the University of Michigan. Dr. Dossett earned her medical degree from Vanderbilt University School of Medicine in 2003, having attended on a United States Navy Health Professions Scholarship. She completed her general surgery residency at Vanderbilt University in 2010, which included a health services research fellowship and completion of an MPH. After residency, Dr. Dossett served on active duty with the United States Navy in several roles stateside and overseas, including completing two deployments supporting combat operations in Afghanistan. After leaving the Navy in 2014, Dr. Dossett completed a clinical fellowship in Complex General Surgical Oncology at Moffitt Cancer Center and joined the faculty of the University of Michigan in 2016.Dr. Dossett specializes in treating patients with melanoma, soft tissue sarcoma, and breast cancer. Her research leverages implementation science frameworks and behavioral strategies to improve healthcare value. As co-director of the Michigan Program for Value Enhancement (MPrOVE), she works to translate value-based research findings into practice at Michigan Medicine and then scale those strategies more broadly to hospitals and healthcare systems. She is a principal investigator for R01s funded by the National Cancer Institute (NCI) and the Agency for Healthcare Research and Quality (AHRQ). She serves as a mentor on several federally funded training grants and career development awards.Dr. Dossett is an active member of several national societies. She serves as an officer in the Association for Academic Surgeons (AAS) and in the executive leadership of the American College of Surgeons (ACS) Cancer Research Program (CRP) and the Surgical Outcomes Club.Clinical Specialization:Dr. Dossett’s clinical focus is on melanoma and non-melanoma skin cancers, sarcoma, and breast cancer. She has expertise in locally and regionally advanced melanoma, breast angiosarcoma, retroperitoneal and pelvic sarcoma, breast conservation therapy, and skin and nipple sparing mastectomy. Dr. Dossett is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Retroperitoneal Liposarcoma, Melanoma, Desmoplastic Small Round Cell Tumor, Mastectomy, and Lymphadenectomy. Dr. Dossett is board certified in Surgery and Complex General Surgical Oncology.

Dr. Cuneo grew up in Northern California. He studied Biological and Environmental Engineering at Cornell University in Ithaca, NY. Dr. Cuneo received his Doctor of Medicine degree from Vanderbilt University School of Medicine in 2007 and completed an internship there in 2008. In 2008 he started his residency in Radiation Oncology at Duke University Medical Center. Dr. Cuneo has been an Assistant Professor in the Department of Radiation Oncology at the University of Michigan since 2012. Dr. Cuneo is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Pancreatic Cancer, Liposarcoma, Liver Cancer, and Pancreaticoduodenectomy. Dr. Cuneo is board certified in Radiation Oncology.

Ajjai Alva is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Alva is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Renal Cell Carcinoma (RCC), Bladder Cancer, Nephrectomy, and Lymphadenectomy.

Dr. Vaishampayan is the Director of the Phase I program at the Rogel Cancer Center, University of Michigan, Ann Arbor MI. Dr. Vaishampayan is a Professor of Internal Medicine and her research is primarily in translational drug development and early phase clinical trials in cancer with a focus on genitourinary malignancies. She has initiated, obtained funding for, and conducted and published many investigator initiated trials with embedded biomarkers and established multidisciplinary collaboration. She has served as site PI of the UO-1 Early Therapeutics Research Grant at Wayne State University. She was also the chair of the solid tumor division of oncology at WSU. She has completed formal leadership traning course and is Fellow of the Advisory Board (FAB). She is the appointed chair of the Advanced Renal committee of SWOG and a member of the Renal task force of the NCI. She is a board member of the Michigan Society of Hematology/Oncology (MSHO) and organizes annual board review course. Additionally, she has served as track leader for the ASCO education committee GU non prostate (Renal and bladder cancer) track. Dr. Vaishampayan attended Wayne State University for her residency and fellowship completion and attended medical school at Byramjee Jeejeebhoy in Pune, India and completed a higher secondary certificate in the field of science at Fergusson College in Pune, India.In her free time, Dr. Vaishampayan enjoys reading, dance, music and travel. Travel, reading (mysteries preferred), follows football. Dr. Vaishampayan is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. She is also highly rated in 36 other conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Vaishampayan is board certified in Medical Oncology.

Laurence Baker is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Baker is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Ewing Sarcoma, Osteosarcoma, and Bone Tumor.

Rajen Mody is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Mody is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Infantile Neutropenia, Glioma, and Bone Marrow Aspiration.

Rama Rao is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Rao is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. She is also highly rated in 36 other conditions, according to our data. Her clinical expertise encompasses Osteosarcoma, Chondrosarcoma, Hereditary Neuroblastoma, Neuroblastoma, and Bone Marrow Aspiration. Dr. Rao is board certified in Pediatric Hematology-Oncology.

Dr. Hearn is an Associate Professor in the Department of Radiation Oncology at the University of Michigan. He completed his medical training at Harvard Medical School and his residency in radiation oncology at Cleveland Clinic. Dr. Hearn investigates mechanisms by which prostate cancer may become resistant to current treatments.Dr. Hearn also treats bladder cancer and has been impressed by the promising responses (sometimes dramatic and long-lasting) that some patients with bladder cancer have when treated with immunotherapy to harness the body’s immune system. He is interested in the intersection of immunotherapy and radiation therapy.Additionally, Dr. Hearn is interested in novel techniques to improve the safety and efficacy of radiation therapy for lung cancer by modulating cytokines relevant to lung injury. Dr. Hearn is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, Muscle Invasive Bladder Cancer, and Prostatectomy. Dr. Hearn is board certified in Radiation Oncology.

Jonathan L. Eliason, M.D., is the S. Martin Lindenauer Collegiate Professor of Vascular Surgery. Dr. Eliason received his undergraduate degree from Bethel College in St. Paul, Minnesota and his medical degree from the University of Minnesota Medical School. He then relocated to Nashville, Tennessee where he completed his General Surgery Residency at Vanderbilt University Medical Center. He became Chief Resident in the 2001-2002 academic year and proceeded into the two-year Vascular Surgery Fellowship at the University of Michigan the following year. Prior to joining the faculty at U-M, Dr. Eliason served as a Clinical Assistant Professor of Surgery at the University of Texas Health Science Center at San Antonio and as a staff surgeon for the San Antonio Military Vascular Surgery Service at Wilford Hall Medical Center and Brooke Army Medical Center. He was deployed to Balad, Iraq as a vascular surgeon in the 332nd Expeditionary Medical Group from 9/06 - 1/07 and was otherwise a member of the 859th Surgical Operations Squadron of the 59th Medical Wing at Lackland Air Force Base in Texas. He joined the faculty at the University of Michigan in the section of vascular surgery in 2007. Dr. Eliason is rated as an Experienced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Thoracic Aortic Aneurysm, Abdominal Aortic Aneurysm (AAA), Peripheral Artery Disease, Carotid Artery Surgery, and Aneurysm Repair. Dr. Eliason is board certified in Vascular Surgery and Surgery.

Mario Lacerna is a Radiation Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Lacerna is rated as an Experienced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Breast Cancer. Dr. Lacerna is board certified in Radiation Oncology.

Dr. Sedig was born and raised in Orlando, Florida. She completed her undergraduate degree in Medical Ethics at Davidson College before returning to Florida to attend the University of Florida College of Medicine. She then went to the University of Wisconsin-Madison for her residency in Pediatrics and then to the University of Michigan for her Pediatric Hematology/Oncology Fellowship. Dr. Sedig is rated as an Experienced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Retinoblastoma, Hepatoblastoma, Hereditary Neuroblastoma, Neuroblastoma, and Bone Marrow Aspiration.

Joshua Goldman is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 10 years. Dr. Goldman is rated as an Experienced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Neuroblastoma, Hereditary Neuroblastoma, Febrile Neutropenia, and Bone Marrow Aspiration. Dr. Goldman is board certified in Pediatrics and Pediatric Hematology-Oncology.

My past and ongoing research is focused on translational studies and clinical trials for children with brain and spinal cord tumors with a special emphasis on ependymoma and ATRT. Children with brain tumors continue to have poor outcomes compared to those with other cancers in this age group. I have analyzed the outcomes of treatment for ATRT and ependymoma in children, combining traditional modes of therapy, such as surgery, chemotherapy, and radiation therapy, with molecularly targeted therapy. In the process we have identified novel clinical and molecular risk factors associated with outcomes. By identifying clinical risk factors associated with poor outcomes in these children, we can tailor therapy to improve outcomes in those at highest risk of treatment failures. Dr. Upadhyaya is rated as an Experienced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Rhabdoid Tumor, Teratoma of the Mediastinum, Glioma, Medulloblastoma, and Bone Marrow Aspiration.

Emily B. Walling MD, MPHS is a Clinical Assistant Professor in the Division of Hematology/Oncology, Department of Pediatrics. Dr. Walling received her bachelor's degree from the University of Wisonsin-Madison and her medical degree from the University of Toledo. Following residency training in pediatrics at the Medical College of Wisconsin, Dr. Walling completed her fellowship training in pediatric hematology-oncology at Washington University where she earned her master's degree in population health sciences. Dr. Walling joined the faculty at Michigan in 2016. She founded and is the co-medical director of the Michigan Medicine Adolescent and Young Adult Oncology Program. Dr. Walling is rated as an Experienced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Hereditary Neuroblastoma, Neuroblastoma, Osteosarcoma, and Bone Marrow Aspiration. Dr. Walling is board certified in Pediatric Hematology-Oncology and Pediatrics.